全文获取类型
收费全文 | 274431篇 |
免费 | 7171篇 |
国内免费 | 630篇 |
专业分类
耳鼻咽喉 | 2124篇 |
儿科学 | 9890篇 |
妇产科学 | 5345篇 |
基础医学 | 30935篇 |
口腔科学 | 5372篇 |
临床医学 | 21504篇 |
内科学 | 53027篇 |
皮肤病学 | 3338篇 |
神经病学 | 26172篇 |
特种医学 | 11141篇 |
外国民族医学 | 1篇 |
外科学 | 37595篇 |
综合类 | 2682篇 |
一般理论 | 48篇 |
预防医学 | 27819篇 |
眼科学 | 4374篇 |
药学 | 16563篇 |
中国医学 | 1031篇 |
肿瘤学 | 23271篇 |
出版年
2023年 | 954篇 |
2022年 | 821篇 |
2021年 | 3163篇 |
2020年 | 2289篇 |
2019年 | 3079篇 |
2018年 | 24788篇 |
2017年 | 19571篇 |
2016年 | 22070篇 |
2015年 | 4262篇 |
2014年 | 5252篇 |
2013年 | 6577篇 |
2012年 | 15647篇 |
2011年 | 29768篇 |
2010年 | 23454篇 |
2009年 | 15520篇 |
2008年 | 26397篇 |
2007年 | 28551篇 |
2006年 | 7228篇 |
2005年 | 8379篇 |
2004年 | 8943篇 |
2003年 | 9264篇 |
2002年 | 6908篇 |
2001年 | 764篇 |
2000年 | 734篇 |
1999年 | 659篇 |
1998年 | 792篇 |
1997年 | 699篇 |
1996年 | 496篇 |
1995年 | 540篇 |
1994年 | 511篇 |
1993年 | 404篇 |
1992年 | 320篇 |
1991年 | 269篇 |
1990年 | 310篇 |
1989年 | 255篇 |
1988年 | 220篇 |
1987年 | 180篇 |
1986年 | 175篇 |
1985年 | 137篇 |
1984年 | 147篇 |
1983年 | 144篇 |
1982年 | 178篇 |
1981年 | 111篇 |
1980年 | 161篇 |
1979年 | 76篇 |
1978年 | 83篇 |
1977年 | 70篇 |
1976年 | 64篇 |
1974年 | 72篇 |
1932年 | 63篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Time to Get Help? Help-Seeking Process in Latin American Hospital Patients with Alcohol Use Disorder
Conde Karina Salomon Tomás Civetta Elida Blanco Maria Cremonte Mariana 《International journal of mental health and addiction》2020,18(2):328-335
International Journal of Mental Health and Addiction - Alcohol Use Disorder (AUD) is one of the most harmful conditions associated with consumption. Despite a high level of consumption and an... 相似文献
72.
AbstractIn light of a growing body of evidence demonstrating pervasive health disparities, medical schools are increasingly incorporating educational programs on social medicine in undergraduate and graduate medical curricula. In 2015, we significantly restructured the cultural competency instruction for medical students at our institution, focusing on achieving greater health equity through caring for vulnerable populations and acknowledging and addressing bias and stereotyping. In order to facilitate educational sustainability while students were immersed in clinical care, a key element of our approach included extending teaching into the clerkship year. The resulting longitudinal thread, Health Equity and Social Justice, empowers future physicians with the knowledge and skills to work towards greater health equity. This article discusses the lessons learned in the implementation of this novel educational program. Our approach can serve as a model for other institutions considering similar instructional reform. 相似文献
73.
Jens Henrik Norum Oliver Frings Maria Kasper Helga Bergholtz Helene Zell Thime Åsa Bergström Agneta Andersson Raoul Kuiper Erik Fredlund Therese Sørlie Rune Toftgård 《International journal of cancer. Journal international du cancer》2020,146(4):1125-1138
Increased expression of GLI1, the main Hedgehog signalling pathway effector, is related to unfavourable prognosis and progressive disease of certain breast cancer subtypes. We used conditional transgenic mice induced to overexpress GLI1 in the mammary epithelium either alone or in combination with deletion of one Trp53 allele to address the role of elevated GLI1 expression in breast tumour initiation and progression. Induced GLI1 expression facilitates mammary gland tumour formation and this was further increased upon heterozygous deletion of Trp53. The GLI1-induced primary tumours were of different murine molecular subtypes, including Normal-likeEx, Class8Ex, Claudin-LowEx and Erbb2-likeEx. The gene expression profiles of some of the tumours correlated well with the PAM50 subtypes for human breast cancer. Whole-exome sequencing revealed somatic mutation profiles with only little overlap between the primary tumours. Orthotopically serially transplanted GLI1-induced tumours maintained the main morphological characteristics of the primary tumours for ≥10 generations. Independent of Trp53 status and molecular subtype, the serially transplanted GLI1-induced tumours were able to grow both in the absence of transgenic GLI1 expression and in the presence of the GLI1 inhibitor GANT61. These data suggest that elevated GLI1 expression has a determinant role in tumour initiation; however, additional genetic events are required for tumour progression. 相似文献
74.
Daniela S. Camilo Fernando Pradella Maria Fernanda Paulino Emilio C. E. Baracat Sofia H. Marini Gil Guerra Elizabeth J. Pavin Candida Parisi Ana Leda F. Longhini Silvia B. Marques Edilaine G. Guariento Sofia R. Lieber Carlos Fernando Macedo Letícia Gama e Silva Alessandro S. Farias Leonilda M. B. Santos Walkyria M. G. Volpini 《Pediatric diabetes》2020,21(4):606-614
75.
76.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
77.
78.
79.
Bo Freyschuss Maria K. Svensson Thomas Cars Lars Lindhagen Helena Johansson Andreas Kindmark 《Journal of bone and mineral research》2022,37(4):649-659
Results from real-world evidence (RWE) from the largest healthcare region in Sweden show low uptake of antiresorptive (AR) treatment, but beneficial effect in those receiving treatment, especially for the composite outcome of hip fracture or death. For RWE studies, Sweden is unique, with virtually complete coverage of electronic medical records (EMRs) and both regional and national registries, in a universal publicly funded healthcare system. To our knowledge, there is no previous RWE study evaluating the efficacy of AR treatment compared to no AR treatment after fragility fracture, including data on parenteral treatments administered in hospital settings. The Stockholm Real World Management (STORM) study cohort was established in the healthcare region of Stockholm to retrospectively assess the effectiveness of AR treatment after first fragility fracture using the regional EMR system for both hospital and primary care. Between 2012 and 2018, we identified 69,577 fragility fracture episodes among 59,078 patients, men and women, 50 years and older. Of those, 21,141 patients met inclusion and exclusion criteria (eligible cohort). From these, the final matched study cohort comprised 9840 fragility fractures (cases receiving AR treatment [n = 1640] and controls not receiving AR treatment [n = 8200]). Propensity scores were estimated using logistic regression models with AR treatment as outcome and confounders as independent variables followed by analysis using Cox proportional hazard models. Real world evidence from Sweden's largest healthcare region, comprising a quarter of the Swedish population, show that only 10% of patients receive AR treatment within 1 year after a fragility fracture. Factors associated with not receiving treatment include having a diagnosis of cardiovascular disease. In those treated, AR have positive effects particularly on the composite of fracture and death (any fracture/death and hip fracture/death) in individuals matched for all major confounders. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). 相似文献
80.
Volungis Adam M. Kalpidou Maria Popores Colleen Joyce Mark 《International journal of mental health and addiction》2020,18(5):1209-1225
International Journal of Mental Health and Addiction - We examined the relationships among smartphone addiction, social-emotional distress (e.g., anxiety, depression, sleep quality, and... 相似文献